(Q54516478)

30 May 2018

title

RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation. (English)

1 reference

30 May 2018

chronic myelomonocytic leukemia

1 reference

1 reference

8

1 reference

30 May 2018

Caroline Deswarte

object named as

C Deswarte

6

0 references

Cyril Broccardo

object named as

C Broccardo

18

0 references

author name string

P Ballerini

1

1 reference

30 May 2018

S Struski

2

1 reference

30 May 2018

C Cresson

3

1 reference

30 May 2018

N Prade

4

1 reference

30 May 2018

S Toujani

5

1 reference

30 May 2018

S Dobbelstein

7

1 reference

30 May 2018

H Lapillonne

9

1 reference

30 May 2018

E-F Gautier

10

1 reference

30 May 2018

C Demur

11

1 reference

30 May 2018

E Lippert

12

1 reference

30 May 2018

P Pages

13

1 reference

30 May 2018

V Mansat-De Mas

14

1 reference

30 May 2018

J Donadieu

15

1 reference

30 May 2018

F Huguet

16

1 reference

30 May 2018

N Dastugue

17

1 reference

30 May 2018

C Perot

19

1 reference

30 May 2018

E Delabesse

20

1 reference

30 May 2018

publication date

19 April 2012

1 reference

30 May 2018

published in

Leukemia

1 reference

30 May 2018

volume

26

1 reference

30 May 2018

issue

11

1 reference

30 May 2018

page(s)

2384-2389

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2012.109

exact match

0 references

cites work

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Activation of a novel human transforming gene, ret, by DNA rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Current concepts in RET-related genetics, signaling and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

KIF5B-RET fusions in lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Renal aplasia in humans is associated with RET mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Finishing the euchromatic sequence of the human genome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

BAY 43-9006 inhibition of oncogenic RET mutants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

A quantitative analysis of kinase inhibitor selectivity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Structural Basis for the Cytoskeletal Association of Bcr-Abl/c-Abl

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Absence of mutations in the RET gene in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

A coiled-coil tetramerization domain of BCR-ABL is essential for the interactions of SH2-containing signal transduction molecules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.109

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.109

1 reference

30 May 2018

Dimensions Publication ID

1007861322

0 references

1 reference

30 May 2018